Assessment of the effect of oral clarithromycin on visual outcome following presumed bacterial endophthalmitis

Reference

• Hughes DS, Hill RJ. Infectious endophthalmitis after cata-ract surgery. British Journal of Ophthalmology. 1994; 78:227–232.
   PubMed Web of Science ®Google Scholar
• Busin M, Cusumano A, Spitznas M. Intraocular lens re-moval from eyes with chronic low-grade endophthalmitis. J Cataract Refract Surg. 1995;21:679–84.
   PubMed Web of Science ®Google Scholar
• Okhravi N, Towler HMA, Hykin P, Matheson MM, Lightman S. Assessment of a standard treatment proto-col on visual outcome following presumed bacterial endophthalmitis. Br J Ophthalmol. 1997;81:719–725.
   Google Scholar
• Kalicharan D, Jongebloed WL, Los LI, Worst JGF. (An)aerobic bacteria found in the secondary-cataract material. A SEM/TEM study. Doc Ophthalmol. 1992; 82:125–133.
   PubMed Web of Science ®Google Scholar
• Okhravi N, Adamson P, Dunlop A, Towler HMA, Matheson MM, Lightman S. PCR-based evidence of bacterial involvement in eyes with suspected intraocu-lar infection. Invest Ophthalmol Vis Sci. 2000. In press.
   Google Scholar
• Okhravi N, Adamson P, Matheson MM, Towler HMA, Lightman S. PCR/RFLP based detection and speciation of bacteria causing endophthalmitis. Invest Ophthalmol Vis Sci. 2000;41:1438–1447.
   PubMed Web of Science ®Google Scholar
• Costerton JW. The etiology and persistence of cryptic bacterial infections: a hypothesis. Rev Infect Dis. 1984;6: S608–616.
   PubMedGoogle Scholar
• Braga PC, Piatti G. Sub-lethal concentrations of clarithro-mycin interfere with the expression of Staphylococcus aureus adhesiveness to human cells. J Chemo. 1993;5: 159–163.
   Google Scholar
• Yasuda H, Ajiki Y, Koga T, Kawada H, Yokota T. In-teraction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrobial Agents & Chemotherapy. 1993 ;37:1749–55.
   Google Scholar
• Braga PC. Effects of subinhibitory concentrations of seven macrolides and four fluoroquinolones on adhesion of Staphylococcus aureus to human mucosal cells. Chemo-therapy. 1994;40:304–310.
   Web of Science ®Google Scholar
• Khoury AE, Lam K, Ellis B, Costerton JW. Prevention and control of bacterial infections associated with medical devices. ASAIO Journal. 1992;38:M174–8.
   PubMedGoogle Scholar
• Reid G, Denstedt JD, Kang YS, Lam D, Nause C. Micro-bial adhesion and biofilm formation on ureteral stents in vitro and in vivo. Journal of Urology. 1992;148:1592–4.
   Google Scholar
• Passerini L, Lam K, Costerton JW, King EG. Biofilms on indwelling vascular catheters. Critical Care Medicine. 1992;20:665–73.
   PubMed Web of Science ®Google Scholar
• Fraschini F, Scaglione F, Demartini G. Clarithromycin clinical pharmakokinetics [Review]. Clinical Pharmaco-kinetics. 1993;25:189–204.
   PubMed Web of Science ®Google Scholar
• Kees F, Spangler S, Wellenhofer M. Determination of macrolides in biological matrices by high-performance liquid chromatography with electrochemical detection. J Chromatogr A. 1998;812:287–293.
   Google Scholar
• Fernandes PB, Bailer R, Swanson R, Hanson CW, McDonald E, Ramer N, Hardy D, Shipkowitz N, Bower RR, Gade E. In vitro and in vivo evaluation of A-56268 ( TE-031), a new macrolide. Antimicrobial agents and chemotherapy. 1986;30:865–873.
   PubMed Web of Science ®Google Scholar
• Gristina AG, Oga M, Webb LX, Hobgood CD. Adher-ent bacterial colonisation in the pathogenesis of osteo-myelitis. Science. 1985;24:990–993.
   Web of Science ®Google Scholar
• Costerton JW. Overview of microbial biofilms. J Ind Microbiol. 1995;15:137–40.
   PubMedGoogle Scholar
• Marrie TJ, Costerton JW. Mode of growth of bacterial pathogens in chronic polymicrobial human osteomyelitis. J Clin Microbiol. 1985;22:924–933.
   PubMed Web of Science ®Google Scholar
• Dominque GJ Sr, Hellstrom WJ. Prostatitis. Clin Micro-biol Rev. 1998;11:604–613.
   PubMed Web of Science ®Google Scholar
• Uetera Y, Yokota T, Hiramatsu K, Sato K, Ogawa M. Role of bacterial biofilms in the chemotherapy of cho-langitis with brown pigment stones. Chemotherapy. 1996;42:363–373.
   Google Scholar
• Reid G, Charbonneau-Smith R, Lam D, Kang YS, Lacerte M, Hayes KC. Bacterial biofilm formation in the urinary bladder of spinal cord injured patients. Paraplegia. 1992; 30:711–717.
   PubMedGoogle Scholar
• Shaarawy A, Grand MG, Meredith TA, Ibanez HE. Per-sistent endophthalmitis after intravitreal antimicrobial therapy. Ophthalmology. 1995;102:382–7.
   PubMed Web of Science ®Google Scholar
• Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomised trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthal-mitis. [see comments]. Arch Ophthalmol. 1995;113:1479–96.
   Google Scholar
• Pflugfelder SC, Hernandez E, Fleisler SJ, Alvarez J, Pflugfelder ME, Forster RK. Intravitreal vancomycin: retinal toxicity, clearance and interaction with gentamicin. Arch Ophthalmol. 1987;105:831–837.
   PubMed Web of Science ®Google Scholar
• Forster RK. Experimental postoperative endophthalmitis. Trans Am Ophthalmol Soc. 1992;90:505–59.
   PubMedGoogle Scholar
• Aguilar HE, Meredith TA, El-Massry A, Shaarawy A, Kincaid M, Dick J, Ritchie DJ, Reichley RM, Neisman MK. Vancomycin levels after intravitreal injection. Retina. 1995;15:428–432.
   Google Scholar
• Ferencz JR, Assia El, Diamantstein L, Rubinstein E. Vancomycin concentrations in the vitreous after intra-venous and intravitreal administration for post-operative endophthalmitis. Arch Ophthalmol. 1999;117:1023–7.
   PubMedGoogle Scholar
• Somani S, Grinbaum A, Slomovic AR. Postoperative endophthalmitis: incidence, predisposing surgery, clinical course and outcome. Can J Ophthalmol. 1997;32:303–10.
   Google Scholar
• Seal DV, Kirkriess CM. Criteria for intravitreal antibiotics during surgical removal of intraocular foreign bodies. Eye. 1992;6:465–8.
   PubMed Web of Science ®Google Scholar
• Coco RM, Lopez MI, Pastor JC, Nozal MJ. Pharmaco-kinetics of intravitreal vancomycin in normal and infected rabbit eyes. J Ocul Pharmacol Ther. 1998;14:555–63.
   PubMed Web of Science ®Google Scholar
• Canvin JM, Goutcher SC, Hagig M, Gemmell CG, Stur-rock RD. Persistence of Staphylococcus aureus as de-tected by polymerase chain reaction in the synovial fluid of patient with septic arthritis. Br J Rheumatol. 1997;36: 203–206.
   Google Scholar
• el-Baba FZ, Trousdale MD, Gauderman WJ, Wagner DG, Liggett PE. Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology. 1992;99:483–6.
   Google Scholar
• Lesk MR, Ammann H, Marcil G, Vinet B, Lamer L, Sebag M. The penetration of oral ciprofloxacin into the aqueous humor, vitreous and subretinal fluid of humans. Am J Ophthalmol. 1993;115:623–658.
   PubMed Web of Science ®Google Scholar
• Davis JL. Intravenous antibiotics for endophthalmitis [editorial; comment]. Am J Ophthalmol. 1996;122:724–6.
   PubMed Web of Science ®Google Scholar
• Ciulla TA. Update on acute and chronic endophthalmitis. Ophthalmology. 1999;106:2237–8.
   PubMed Web of Science ®Google Scholar
• Abbott Laboratories Product Monograph. Klaricid: The first of a new generation of macrolide antibiotics. Abbott House, Maidenhead, Berkshire: Abbott laboratories, 1991; 1–32.
   Google Scholar
• Al-Sibai MB, Al-Kaff AS, Raines D, El-Yazigi A. Ocular penetration of oral clarithromycin in humans. J Ocul Pharmacol Ther. 1998;14:575–583.
   PubMed Web of Science ®Google Scholar
• Altman DG. Practical statistics for medical research. First ed. London: Chapman and Hall, 1991.
   Google Scholar